Abstract:Background: Hepatic macrophages play an indispensable role in liver pathophysiology, serving as key orchestrators of both liver injury and repair processes. ATG16L1 (autophagy-related 16 like 1) has emerged as a novel and critical autophagy marker. In macrophages, ATG16L1 assumes a particularly crucial role. The current understanding of how macrophage ATG16L1 regulates liver inflammation in the context of liver fibrosis is unclear. Methods: This study included clinical patient samples of liver fibrosis and established a murine model with myeloid-specific Atg16l1 knockout, creating a mouse model of liver fibrosis. Employing RNA sequencing, we sought to elucidate the mechanisms of macrophage ATG16L1 in liver fibrosis by identifying critical signaling pathways. To assess the influence of macrophage ATG16L1 on hepatocyte apoptosis and hepatic stellate cell (HSC) activation, we constructed a dedicated culture system. Ultimately, the introduction of mice with myeloid-specific Atg16l1 knock-in substantiated the protective role of myeloid-specific Atg16l1 against inflammatory signaling, hepatocyte apoptosis, and activation of HSCs. Results: An upregulation of the ATG16L1 signal was observed in the liver tissues of patients with liver fibrosis and in fibrotic mice, predominantly localized to hepatic macrophages. In Atg16l1 ΔMφ mice afflicted with liver fibrosis, we detected exacerbated liver damage, evidenced by heightened inflammatory signal expression, increased hepatocyte apoptosis, and enhanced activation of HSCs. The absence of macrophage Atg16l1 was found to result in elevated TNF receptor-associated factor 1 (TRAF1) signaling, triggering inflammatory activation, intensifying hepatocyte apoptosis, and facilitating HSC activation through the transforming growth factor beta 1 (TGF-β1) signaling. The detrimental effects of macrophage Atg16l1 depletion were demonstrated to be mitigated upon Atg16l1 reintroduction. Conclusions: This research delved into the mechanisms by which the macrophage ATG16L1 signal influences inflammatory signaling, hepatocyte apoptosis, and activation of HSCs in liver fibrosis. Consequently, it offers theoretical substantiation and an experimental groundwork for the identification of biological targets for therapeutic intervention in liver fibrosis.

Activation of AMPKα1 is essential for regulatory T cell function and autoimmune liver disease prevention

Regulation Of Cd8(+) Regulatory T Cells: Interruption Of The Nkg2a-Qa-1 Interaction Allows Robust Suppressive Activity And Resolution Of Autoimmune Disease

AMP-activated protein kinase alpha1 promotes tumor development via FOXP3 elevation in tumor-infiltrating Treg cells

Regulatory T Cells Ameliorate Acetaminophen-Induced Immune-Mediated Liver Injury.

Lkb1 orchestrates γδ T-cell metabolic and functional fitness to control IL-17-mediated autoimmune hepatitis

Engaging natural regulatory myeloid cells to restrict T-cell hyperactivation-induced liver inflammation via extracellular vesicle-mediated purine metabolism regulation

Liver-specific T regulatory type-1 cells program local neutrophils to suppress hepatic autoimmunity via CRAMP

Activated Hepatic Stellate Cells Promote Expression of Regulatory T Cells

A pathogenic role for regulatory T cells in chronic liver disease

Decreased Foxp3 and Function of Tregs Caused Immune Imbalance and Liver Injury in Patients with Autoimmune Liver Diseases Post-Liver Transplantation

Immune Regulation of Intrahepatic Regulatory T Cells in Fibrotic Livers of Mice.

AMPK promotes antitumor immunity by downregulating PD-1 in regulatory T cells via the HMGCR/p38 signaling pathway

Survival and Maintenance of Regulatory T Cells Require the Kinase Tak1

CD4+CD25+ Foxp3+ Regulatory T Cells Protect Against T Cell-Mediated Fulminant Hepatitis in a TGF-β-Dependent Manner in Mice

Regulation of Liver Regeneration by T Cell‐ Derived Lymphotoxin

Non-oxidative pentose phosphate pathway controls regulatory T cell function by integrating metabolism and epigenetics

Regulatory T cells ameliorate acetaminophen-induced immune<i>-</i>mediated liver injury (IRC11P.439)

AMPK Hyperactivity Maintains the Survival of Vasculogenic T Cells in Patients with Takayasu's Arteritis

Liver kinase B1 (LKB1) staves off γδ T-cell-mediated autoimmune liver disease

Regulatory T cells (Tregs) in liver fibrosis

ATG16L1 Depletion-Mediated Activation of the TRAF1 Signaling in Macrophages Aggravates Liver Fibrosis